Free tool
FAERS Monitor: Symbicort
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 021929 or its brand name (Symbicort, Budesonide, Formoterol Fumarate Dihydrate). Reports on generic versions are filed under their own applications.
Reports
97,875
Serious
59,185
60% of reports
Hospitalization
28,594
Death reported
6,740
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- dyspnoea17,904
- asthma12,227
- cough8,045
- drug ineffective6,922
- off label use5,977
- pneumonia5,945
- wheezing5,768
- fatigue5,483
- malaise4,658
- headache4,655
- chronic obstructive pulmonary disease4,067
- nausea4,063
- death3,844
- drug dose omission3,643
- intentional product misuse3,558
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 50 |
| 2005 | 84 |
| 2006 | 122 |
| 2007 | 385 |
| 2008 | 1,061 |
| 2009 | 1,445 |
| 2010 | 2,520 |
| 2011 | 3,764 |
| 2012 | 4,860 |
| 2013 | 2,977 |
| 2014 | 4,356 |
| 2015 | 5,965 |
| 2016 | 7,206 |
| 2017 | 6,586 |
| 2018 | 7,229 |
| 2019 | 7,850 |
| 2020 | 8,937 |
| 2021 | 6,807 |
| 2022 | 5,616 |
| 2023 | 5,468 |
| 2024 | 5,820 |
| 2025 | 4,948 |
| 2026 | 3,819 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,956,284 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| asthmaSignal | 12,227 | 25.9 | 25.5 | 262,952 |
| wheezingSignal | 5,768 | 23.0 | 22.4 | 110,102 |
| chronic obstructive pulmonary diseaseSignal | 4,067 | 18.1 | 17.5 | 60,645 |
| intentional product misuseSignal | 3,558 | 9.1 | 8.8 | 24,573 |
| dyspnoeaSignal | 17,904 | 7.0 | 6.9 | 91,379 |
| coughSignal | 8,045 | 6.3 | 6.2 | 35,441 |
| drug dose omissionSignal | 3,643 | 4.8 | 4.7 | 10,868 |
| pneumoniaSignal | 5,945 | 4.0 | 3.9 | 13,339 |
| malaiseSignal | 4,658 | 2.3 | 2.2 | 3,442 |
| headache | 4,655 | 1.6 | 1.6 | 1,071 |
| fatigue | 5,483 | 1.5 | 1.5 | 996 |
| off label use | 5,977 | 1.5 | 1.4 | 931 |
| drug ineffective | 6,922 | 1.1 | 1.1 | 109 |
| nausea | 4,063 | 1.1 | 1.1 | 41 |
| death | 3,844 | 1.0 | 0.9 | 7 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.